Search

Filters

Clear Filters
8:40 AM - 8:50 AM ET

153 - Alternative Cancer Treatment Clinics in North America: Evidence Gaps, Regulatory Concerns, and Financial Burden
Speaker: El Kouzi, Zakaria, MD - MD Anderson Cancer Center, Houston, TX
8:00 AM - 8:10 AM ET

154 - Is Clinical Target Volume Necessary in Limited-Stage Small Cell Lung Cancer? A Large-Scale Comparative Study
Speaker: Wang, Xiaolong - Cancer Center, Shandong University, Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong, Jin, jinan
8:10 AM - 8:20 AM ET

155 - Post-Chemoradiotherapy Molecular Residual Disease (MRD) Clearance Determines Long-Term Survival in Limited-Stage Small Cell Lung Cancer: A Prospective Longitudinal Study
Speaker: Tian, Yaru - Shandong Cancer Hospital and Institute, Jinan
8:20 AM - 8:30 AM ET

156 - Prognostic Value of Baseline Genomic Profiling and Longitudinal ctDNA-Based MRD Monitoring in Limited-Stage Small-Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Speaker: Huo, Siyuan - Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer and Tianjin Key Laboratory of Cancer Prevention and Therapy, Ti, Tianjin
8:30 AM - 8:40 AM ET

157 - Postoperative Hypofractionated Radiotherapy for Thymic Epithelial Tumors: Efficacy and Safety Results from a Prospective, Single-Center, Phase II Trial
Speaker: Zhang, Zhihui, MD, PhD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing, Beijing
8:40 AM - 8:50 AM ET

158 - Combining SBRT with GM-CSF and Peg-IFNa to Induce Abscopal Effects In Previously Treated Patients with Metastatic Thymic Tumors: A Single Institution, Phase II Trial
Speaker: Fan, Min, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
8:00 AM - 8:10 AM ET

159 - Predicting Dysphagia and Identifying Anatomical Regions Responsible for Dysphagia Following Intensity-Modulated Radiation Therapy (IMRT) for Oropharyngeal Carcinoma
Speaker: Das, Shiva, PhD - University of North Carolina, Chapel Hill, NC
8:10 AM - 8:20 AM ET

160 - Subregional Parotid Dosiomics and DVH Integration Improves Prediction of Xerostomia after Radiotherapy for Nasopharyngeal Carcinoma
Speaker: Sun, Hongfei, PhD - Xijing Hospital, Xian 710032, Shaanxi
8:20 AM - 8:30 AM ET

161 - Evaluating CT-based Radiomics and Dosiomics Outcome Models for Locoregionally Advanced Head and Neck Cancer: A Retrospective Analysis of the NRG/RTOG 0522 trial
Speaker: Tie, Xin, PhD - University of Pennsylvania, Philadelphia, PA
8:30 AM - 8:40 AM ET

162 - Pilot Clinical Implementation and Evaluation of an AI-Based Decision Support Tool for CBCT-Guided Radiotherapy Image Review
Speaker: Luximon, Dishane, PhD - University of California Los Angeles, Los Angeles, CA
8:40 AM - 8:50 AM ET

163 - Cross-Institutional Validation of LLM-Based Cardiac Event Extraction from Electronic Health Records
Speaker: Cao, Wenchao, PhD - Thomas Jefferson University, Philadelphia, PA
8:50 AM - 9:00 AM ET

164 - Feature Interaction-Informed Deep Radiomics Unveils Tumor Heterogeneity and Predicts Distant Metastasis-Free Survival in Head and Neck Cancer: A Multicenter Study
Speaker: Xing, Lei, PhD, FASTRO - Stanford University, Stanford University, CA